About this trial
The purpose of this study, is to investigate whether creatine monohydrate as a supplement reduces the number and severity of symptoms in patients with persistent post-concussive symptoms through self-reported post-concussion symptoms questionnaires.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Have had PPCS for a minimum of six months and a maximum of 18 months at the start of the study.
Being between 20 and 45 years of age
Disqualifiers
Elite athletes, as well as people who in general is physical active, at an intensity of moderat to high, for more than ten hours a week on average.
Participation in other interventions/treatment that could affect this study
=<6 months
=>18 months
Trial design
Parallel
Treatments tested in this trial
Creatine Monohydrate
Dietary supplementFollows
Treatment groups
Trial outcomes
Primary outcomes
Change from Baseline Post-Concussion Symptoms at 7 weeks
Rivermead Post-Concussion Symptom Questionnaire
Secondary outcomes
Change from Baseline Body weight at 7 weeks
As we are using a dietary supplement as our intervention, following participants body weight in kg throughout the intervention is necessary in order to know if changes in body weight have any effect on our results.
Other outcomes
Height
Descriptive measurement
Training status
To determine if the participants are at the same initial training status.
Period with PPCS
To assess persistent post-concussive symptoms
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Psychiatric Research Unit, Region Zealand, Denmark
Lead sponsor
University of Southern Denmark
Collaborator